Literature DB >> 20691423

Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures.

Anne L Coleman1, Fei Yu, Kristine E Ensrud, Katie L Stone, Jane A Cauley, Kathryn L Pedula, Marc C Hochberg, Carol M Mangione.   

Abstract

PURPOSE: To assess vision-specific quality of life (QOL), based on abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire (NEI-VFQ), in a cohort of United States women who participated in the Study of Osteoporotic Fractures.
DESIGN: Prospective, observational cohort study.
METHODS: Age-related macular degeneration (AMD) status, based on a 3-level classification (no AMD, early AMD, late AMD), and vision-specific QOL, based on abbreviated NEI-VFQ surveys, were calculated for 1674 women enrolled in the Study of Osteoporotic Fractures at 4 centers within the United States who had gradable fundus photographs at both the 10-year and 15-year follow-up visits. The associations among 5-year changes in NEI-VFQ composite scores, change in AMD status, and distance visual acuity were examined.
RESULTS: Compared with study participants without AMD at both visits, study participants with late AMD at both visits and those who progressed from early AMD to late AMD demonstrated the greatest declines in adjusted NEI-VFQ composite scores, up to a mean decrease of 16.2 from a scale of 100. Visual acuity declines also were most prominent for patients with late AMD at both visits and for those who progressed from early AMD to late AMD. Change in visual acuity was found to correlate significantly with change in vision-specific QOL.
CONCLUSIONS: The abbreviated NEI-VFQ surveys provide reliable assessments of vision-specific QOL in AMD patients. The decline in vision-specific QOL associated with the progression of AMD is clinically meaningful.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20691423      PMCID: PMC2967587          DOI: 10.1016/j.ajo.2010.05.030

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  38 in total

1.  Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.

Authors:  Melissa M Brown; Gary C Brown; Sanjay Sharma; Jennifer Landy; Jeff Bakal
Journal:  Arch Ophthalmol       Date:  2002-04

2.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

3.  Utility values and age-related macular degeneration.

Authors:  G C Brown; S Sharma; M M Brown; J Kistler
Journal:  Arch Ophthalmol       Date:  2000-01

4.  Risk factors for age-related macular degeneration: Pooled findings from three continents.

Authors:  W Smith; J Assink; R Klein; P Mitchell; C C Klaver; B E Klein; A Hofman; S Jensen; J J Wang; P T de Jong
Journal:  Ophthalmology       Date:  2001-04       Impact factor: 12.079

5.  Assessment of vision-related function in patients with age-related macular degeneration.

Authors:  Paul J Mackenzie; Tom S Chang; Ingrid U Scott; Mark Linder; Dawn Hay; William J Feuer; Keith Chambers
Journal:  Ophthalmology       Date:  2002-04       Impact factor: 12.079

6.  Causes and prevalence of visual impairment among adults in the United States.

Authors:  Nathan Congdon; Benita O'Colmain; Caroline C W Klaver; Ronald Klein; Beatriz Muñoz; David S Friedman; John Kempen; Hugh R Taylor; Paul Mitchell
Journal:  Arch Ophthalmol       Date:  2004-04

7.  Prevalence of age-related macular degeneration in the United States.

Authors:  David S Friedman; Benita J O'Colmain; Beatriz Muñoz; Sandra C Tomany; Cathy McCarty; Paulus T V M de Jong; Barbara Nemesure; Paul Mitchell; John Kempen
Journal:  Arch Ophthalmol       Date:  2004-04

8.  Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.

Authors:  Li Ming Dong; Ashley L Childs; Carol M Mangione; Eric B Bass; Neil M Bressler; Barbara S Hawkins; Marta J Marsh; Päivi Miskala; Harrris A Jaffee; Lee A McCaffrey
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

9.  Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).

Authors:  Maureen Maguire
Journal:  Ophthalmology       Date:  2004-07       Impact factor: 12.079

10.  Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.

Authors:  Päivi H Miskala; Barbara S Hawkins; Carol M Mangione; Eric B Bass; Neil M Bressler; Li Ming Dong; Marta J Marsh; Lee D McCaffrey
Journal:  Arch Ophthalmol       Date:  2003-04
View more
  18 in total

1.  The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary.

Authors:  U Chakravarthy; M Williams
Journal:  Eye (Lond)       Date:  2013-10-25       Impact factor: 3.775

2.  Age-related macular degeneration and mortality in older women: the study of osteoporotic fractures.

Authors:  Kathryn L Pedula; Anne L Coleman; Fei Yu; Jane A Cauley; Kristine E Ensrud; Marc C Hochberg; Howard A Fink; Teresa A Hillier
Journal:  J Am Geriatr Soc       Date:  2015-05-04       Impact factor: 5.562

3.  DISCORDANCE BETWEEN BLUE-LIGHT AUTOFLUORESCENCE AND NEAR-INFRARED AUTOFLUORESCENCE IN AGE-RELATED MACULAR DEGENERATION.

Authors:  Michael J Heiferman; Amani A Fawzi
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

4.  Medicare costs for neovascular age-related macular degeneration, 1994-2007.

Authors:  Shelley Day; Kofi Acquah; Paul P Lee; Prithvi Mruthyunjaya; Frank A Sloan
Journal:  Am J Ophthalmol       Date:  2011-08-16       Impact factor: 5.258

5.  Age-Related Macular Degeneration: Epidemiology and Clinical Aspects.

Authors:  Tiarnán D L Keenan; Catherine A Cukras; Emily Y Chew
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Seeing the patient's perspective: a guide to patient-reported outcome measures and minimal important differences in ophthalmic research.

Authors:  Anila Qasim; Tahira Devji; Mark R Phillips; Charles C Wykoff; Peter K Kaiser; Lehana Thabane; Mohit Bhandari; Varun Chaudhary
Journal:  Eye (Lond)       Date:  2022-02-23       Impact factor: 4.456

Review 7.  The complement system in age-related macular degeneration.

Authors:  Angela Armento; Marius Ueffing; Simon J Clark
Journal:  Cell Mol Life Sci       Date:  2021-03-09       Impact factor: 9.261

8.  Central geographic atrophy vs. neovascular age-related macular degeneration: differences in longitudinal vision-related quality of life.

Authors:  Aneesha Ahluwalia; Liangbo L Shen; Lucian V Del Priore
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-08-19       Impact factor: 3.535

9.  Healthcare Resource Utilization and Costs in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Authors:  Ashley Kim; Beth Devine; Joanna Campbell; Elaheh Shirneshan; Changgeng Zhao; Aasthaa Bansal
Journal:  Clin Ophthalmol       Date:  2021-06-23

10.  The Impact of Vision Impairment (IVI) Questionnaire; Validation of the Thai-Version and the Implementation on Vision-Related Quality of Life in Thai Rural Community.

Authors:  Mansing Ratanasukon; Jongjit Tongsomboon; Patama Bhurayanontachai; Pichai Jirarattanasopa
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.